Search Results 551-560 of 19674 for autoimmune hepatitis
No patient enrollment will occur at MDACC. All patient recruitment will occur at external sites that are a part of the CPDPC. The data management systems, ...
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label- ...
The research program of Alina M. Allen, M.D., at Mayo Clinic is focused on improving outcomes for patients with nonalcoholic fatty liver disease (NAFLD).
PBC, primary sclerosing cholangitis, autoimmune hepatitis, or overlap syndrome;; Alcoholic liver disease;; Wilson disease, hemochromatosis, or iron overload ...
Yataco, M.D., studies the management of nonalcoholic fatty liver disease, as well as complications and patient outcomes after liver transplantation. Her ...
... liver disease, Primary sclerosing cholangitis, Cholangiocarcinoma, Portal hypertension, Liver cancer, Alcoholic hepatitis, Autoimmune hepatitis, Amyloidosis ...
Correlation of Hepatic MR Elastography with Histopathology and/or Abdominal MRI in Patients with Chronic Liver Disease and Malignancy · More about research at ...
syndrome and fatty liver disease, and many of them don't even know that they have it." The silent disease. Nonalcoholic fatty liver disease is referred to as a ...
Alcoholic liver disease;; Primary biliary cholangitis;; Primary sclerosing cholangitis;; Autoimmune hepatitis;; Wilson's disease, hemochromatosis, or iron ...
e renal disease, Cirrhosis, Alcoholic liver disease, Primary sclerosing cholangitis, Cholangiocarcinoma, Portal hypertension, Liver cancer, Autoimmune hepatitis ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.